CoreTissue BioEngineering

Medical Devices & EquipmentSeries AYokohama-shi, Japancoretissue.com

Latest round

Series A

Last raised

Feb 2023

Total raised

$4M

Investors

6

About CoreTissue BioEngineering

CoreTissue BioEngineering Inc.Founded in 2016, CoreTissue BioEngineering Inc. is based in Yokohama-shi, Japan, and focuses on the development of advanced medical devices for ligament reconstruction.CoreTissue BioEngineering Inc. specializes in developing tissue-engineered ligaments designed for anterior cruciate ligament (ACL) reconstruction. Their proprietary decellularization technology regenerates damaged tissues, aiding recovery for athletes.CoreTissue BioEngineering generates revenue from the sales of its medical devices for ligament reconstruction through direct B2B transactions with healthcare institutions.In November 2025, CoreTissue BioEngineering Inc.

Who invested in CoreTissue BioEngineering

6 investors across 1 round

See all investors in CoreTissue BioEngineering

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 24, 2023

    Amount

    $4M

    Investors

    Locked

Questions about CoreTissue BioEngineering

Who invested in CoreTissue BioEngineering?

CoreTissue BioEngineering has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has CoreTissue BioEngineering raised?

CoreTissue BioEngineering has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did CoreTissue BioEngineering last raise money?

CoreTissue BioEngineering's most recent round on record is a Series A, in Feb 2023.

What does CoreTissue BioEngineering do?

CoreTissue BioEngineering is a medical devices & equipment company.

Where is CoreTissue BioEngineering headquartered?

CoreTissue BioEngineering is headquartered in Yokohama-shi, Japan.

Which VCs invest in companies like CoreTissue BioEngineering?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at CoreTissue BioEngineering's stage. Their profiles are linked below.

Raising like CoreTissue BioEngineering? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.